A Better Drug Than Merck’s Blockbuster Keytruda? Not So Fast – The Wall Street Journal September 10, 2024 Medicine A Better Drug Than Merck’s Blockbuster Keytruda? Not So Fast The Wall Street Journal With a win in lung cancer, biotech’s wealthiest outsider surfs to new heights STAT Merck Stock Falls After Rival Summit Beats Keytruda Cancer Drug in Trial Barron’s Akeso, Summit’s PD-1 bispecific crushes… Source link
September 10, 2024 Medicine A Better Drug Than Merck’s Blockbuster Keytruda? Not So Fast The Wall Street Journal With a win in lung cancer, biotech’s wealthiest outsider surfs to new heights STAT Merck Stock Falls After Rival Summit Beats Keytruda Cancer Drug in Trial Barron’s Akeso, Summit’s PD-1 bispecific crushes… Source link